January 30, 2019
Post-Authorization Safety Study of GSK Biologicals’ Pandemic Influenza Vaccine (H1N1) in the United Kingdom
Read More
January 30, 2019
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer’s Disease
Read More
December 10, 2018
A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial Hypercholesterolemia
Read More
December 10, 2018
The APPROACH Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome
Read More
X